Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.
about
Identifying vaccine targets for anti-leishmanial vaccine developmentTh1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.HisAK70: progress towards a vaccine against different forms of leishmaniosis.DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi.Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.
P2860
Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@ast
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@en
type
label
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@ast
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@en
prefLabel
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@ast
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@en
P2093
P2860
P356
P1433
P1476
Mitigating an undesirable immu ...... oantigenic HISA70 DNA vaccine.
@en
P2093
Aldara Herrero-Gil
Gustavo Domínguez-Bernal
Javier Carrión
José A Orden
Lara Ordóñez-Gutiérrez
Pilar Horcajo
Ricardo De La Fuente
P2860
P2888
P356
10.1186/1297-9716-43-59
P577
2012-08-09T00:00:00Z